NEOpTTL | Innovative approach to an Individualised T-Cell Immunotherapy for cancer, using Personalised Tumour Trained Lymphocytes (pTTL) that is reliable, cost-effective, scalable and easy to implement
01-11-2023
-31-01-2026
Show more information
Organisation
NEOGAP THERAPEUTICS AB